In Rare/Orphan disease space, where innovators may lack the commercial capabilities of footprint to reach broader markets, it may take from several years to a decade before patients can access often life-saving therapy. APRaD is an emerging force aiming to close this gap in markets we operate.
We set on a mission to accelerate innovative rare disease treatments to patients in Russia and CIS countries by providing the innovators with experience and capabilities in Market Access, Commercial, Medical, and Marketing.
We offer a comprehensive set of capabilities to enable emerging biotech and pharmaceutical companies reach patients and markets in Russia and CIS countries, including Regulatory, Market Access, Medical Affairs, Early Access Programs, Patient Support Programs, Marketing & Sales, Distribution & Logistics.
We bring service and dedication to bridge the latest biotech and pharmaceutical discoveries and those who need them most.